title: Sitagliptin successfully ameliorates glycemic control in Werner syndrome with diabetes.
authors.forename: Takumi
authors.initials: T
authors.lastname: Kitamoto
authors.forename: Minoru
authors.initials: M
authors.lastname: Takemoto
authors.forename: Masaki
authors.initials: M
authors.lastname: Fujimoto
authors.forename: Takahiro
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Shunichiro
authors.initials: S
authors.lastname: Onishi
authors.forename: Emiko
authors.initials: E
authors.lastname: Okabe
authors.forename: Ryoichi
authors.initials: R
authors.lastname: Ishibashi
authors.forename: Kazuki
authors.initials: K
authors.lastname: Kobayashi
authors.forename: Harukiyo
authors.initials: H
authors.lastname: Kawamura
authors.forename: Koutaro
authors.initials: K
authors.lastname: Yokote
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000627:therapeutic use*; D014898:Werner Syndrome / Q000188:drug therapy*
chemical_list: D001786:Blood Glucose; D054873:Dipeptidyl-Peptidase IV Inhibitors; D011719:Pyrazines; D014230:Triazoles; D000068900:Sitagliptin Phosphate